Elevance Health, Inc. Common Stock (ELV)
360.67
+1.60 (0.45%)
NYSE · Last Trade: Dec 15th, 6:25 PM EST
As 2025 draws to a close, Elevance Health highlights how today’s health plans are evolving to better support their members in a broader range of situations that affect health, including cancer diagnoses, mental health crises, and unexpected health concerns during pregnancy. From employer-sponsored health insurance to government-sponsored programs, health plans are evolving to better support their members in a broader range of situations that affect health. In partnership with care providers, health plans strive to simplify the healthcare experience, personalize care, improve quality, and work with community organizations to improve health outcomes.
By Elevance Health, Inc. · Via Business Wire · December 12, 2025
AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICRs) of “a+” (Excellent) of the core Blue Cross Blue Shield (BCBS)-branded insurance subsidiaries of Elevance Health, Inc. (Elevance) (Indianapolis, IN) [NYSE: ELV], as well as most of its non-Blue-branded subsidiaries. In addition, AM Best has upgraded the FSR to A (Excellent) from A- (Excellent) and the Long-Term ICR to “a+” (Excellent) from “a-” (Excellent) of Wellpoint Life and Health Insurance Company and Wellpoint West Virginia, Inc. These companies collectively are referred to as Anthem Health. At the same time, AM Best has affirmed the Long-Term ICR of “bbb+” (Good), the Long- and Short-Term Issue Credit Ratings (Long-Term IR; Short-Term IR) of Elevance and the Long-Term IR on the existing surplus notes of Anthem Insurance Companies, Inc. (Indianapolis, IN).
By AM Best · Via Business Wire · December 12, 2025
The board of directors of Elevance Health (NYSE: ELV) today announced the appointment of Amy Schulman, a recognized healthcare executive, investor, and governance leader, as an independent director, effective January 12, 2026. Schulman will serve on the Audit and Finance Committees, contributing deep expertise in healthcare innovation, regulatory strategy, and value creation across complex, global enterprises.
By Elevance Health, Inc. · Via Business Wire · December 10, 2025
Elevance Health announced today that it expanded access of its Virtual Assistant, a digital experience designed to help members easily access information, understand their benefits, and find care with confidence. Available through the Sydney Health app and Elevance Health–affiliated health plan websites, Virtual Assistant uses conversational technology to simplify healthcare navigation and improve engagement between members and their health plans.
By Elevance Health, Inc. · Via Business Wire · December 5, 2025
Saurabh Tandon, Elevance Health’s chief experience officer, shared his thoughts on what healthcare has learned from consumer-focused industries, such as streaming services; how to foster consumer loyalty; and what the healthcare experience of the future might look like:
By Elevance Health, Inc. · Via Business Wire · November 24, 2025
Elevance Health, Inc. (NYSE: ELV) reported third quarter 2025 results.
By Elevance Health, Inc. · Via Business Wire · October 21, 2025
PHILADELPHIA, Oct. 04, 2025 (GLOBE NEWSWIRE) --
By Grabar Law Office · Via GlobeNewswire · October 4, 2025
Elevance Health (NYSE: ELV) will release third quarter 2025 financial results on October 21, 2025, at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers:
By Elevance Health, Inc. · Via Business Wire · September 29, 2025
Indianapolis Public Schools' Northwest Middle School today celebrated the unveiling of its newly transformed weight room, a project made possible through a partnership with Elevance Health and the Impact Fitness Foundation (IFF). The initiative is part of Elevance Health’s ongoing commitment to the whole health of communities and is the fourth fitness space upgrade made in an Indianapolis school, in celebration of the Elevance Health Women’s Fort Myers Tipoff, a premier collegiate basketball tournament held each November.
By Elevance Health, Inc. · Via Business Wire · September 24, 2025
PHILADELPHIA, Sept. 23, 2025 (GLOBE NEWSWIRE) --
By Grabar Law Office · Via GlobeNewswire · September 23, 2025
PHILADELPHIA, Sept. 17, 2025 (GLOBE NEWSWIRE) --
By Grabar Law Office · Via GlobeNewswire · September 17, 2025
PHILADELPHIA, Sept. 16, 2025 (GLOBE NEWSWIRE) --
By Grabar Law Office · Via GlobeNewswire · September 16, 2025
PHILADELPHIA, Sept. 10, 2025 (GLOBE NEWSWIRE) --
By Grabar Law Office · Via GlobeNewswire · September 10, 2025
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Elevance (ELV) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · September 9, 2025
Elevance Health and the National Association of Community Health Centers (NACHC) are proud to announce the integration of Food as Medicine (FAM) programming with primary care Community Health Centers (CHCs). This milestone - built on a shared commitment to whole health and community-centered innovation - marks a transformative step forward in addressing food/nutrition insecurity and diet-related chronic conditions through clinical integration.
By Elevance Health, Inc. · Via Business Wire · August 18, 2025
The board of directors of Elevance Health (NYSE: ELV) announced today that Steve Collis, a highly regarded global healthcare executive, will be joining the company’s board, effective August 1. He will also serve on the board’s Audit and Finance Committees, further enhancing the board’s industry expertise and financial oversight capabilities. His addition is part of the board’s ongoing commitment and structured approach to refresh its membership in support of the company’s strategy, stakeholder needs, and the broader healthcare landscape.
By Elevance Health, Inc. · Via Business Wire · July 28, 2025
A groundbreaking clinical trial led by multidisciplinary researchers found that a digital asthma self-management (DASM) program significantly improved asthma symptom control in adults, with benefits sustained over 12 months. Program participants used everyday devices - like Apple Watch and iPhone – along with a tailored mobile app to help them manage their asthma. The findings represent some of the most compelling evidence to date supporting the use of digital health technologies in asthma care.
By Elevance Health, Inc. · Via Business Wire · July 22, 2025
Elevance Health, Inc. (NYSE: ELV) reported second quarter 2025 results.
By Elevance Health, Inc. · Via Business Wire · July 17, 2025
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Elevance (ELV) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · July 15, 2025
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Elevance Health (ELV) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · July 11, 2025
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Elevance To Contact Him Directly To Discuss Their Options
By Faruqi & Faruqi LLP · Via GlobeNewswire · July 11, 2025
NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Elevance Health, Inc. (“Elevance” or the “Company”) (NYSE: ELV). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
By Pomerantz LLP · Via GlobeNewswire · July 10, 2025
PHILADELPHIA, July 08, 2025 (GLOBE NEWSWIRE) -- Berger Montague PC advises investors that a securities class action lawsuit has been filed against Elevance Health, Inc. (“Elevance” or the “Company”) (NYSE: ELV) on behalf of purchasers of Elevance securities between April 18, 2024 through October 16, 2024, inclusive (the “Class Period”).
By Berger Montague · Via GlobeNewswire · July 8, 2025
NEW YORK, July 08, 2025 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · July 8, 2025
The Law Offices of Frank R. Cruz reminds investors of the upcoming July 11, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Elevance Health, Inc. (“Elevance” or the “Company”) (NYSE: ELV) common stock between April 18, 2024, and October 16, 2024, inclusive (the “Class Period”).
By The Law Offices of Frank R. Cruz · Via Business Wire · July 8, 2025